|
Success Stories
Ometric Corporation
Research developed by Dr. Michael Myrick and licensed from
USC has led to the
formation of Ometric, a knowledge-based company that delivers
continuous, in-line measurement and control of chemical processes. Ometric's SpectrInline Processware™ uses near-infrared
spectroscopy to provide pharmaceutical companies with 100% real-time
final product testing on drug tablets at a rate of 18,000 tablets
per hour (five per second). In 2006, Ometric secured a
contract to apply its measurement techniques for pharmaceutical
giant GlaxoSmithKline, Inc.
InstaBone™
InstaBone™ is a calcium phosphate-based bone material in the
form of a moldable paste that interweaves itself into native bone,
has superior compressive strength, and is most effective in healing
craniofacial reconstruction and long bone fixation. This
technology was licensed in 2003 to Competitive Technologies,
Inc, a global leader in commercializing university and company
inventions. Competitive Technologies plans to develop InstaBone™ technology
and estimates that the combined market for all potential
applications of this invention exceeds $2 billion.
Future Fuel Initiatives
USC continues to have global influence on fuel cell technologies with
the continued development of the University of South Carolina Center
for Fuel Cell Research (CRC). The Center works with the
National Science Foundation to lead the nation in research on fuel
cell performance, hydrogen storage materials, new catalysts for
reforming hydrogen from hydrocarbon fuels, and proton-exchange
membrane fuel cells. The Intellectual Property Office works with the
NSF and the CRC to enhance the scope of technology ownership by USC
and University faculty, staff and students.
|
